The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS
Title:
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS
Author:
Guerard, Pascal Rakotoniaina, Zo Goirand, Françoise Rochette, Luc Dumas, Monique Lirussi, Frederic Bardou, Marc